NEW HAVEN, Conn.--(BUSINESS WIRE)--Nov. 1, 2005--HistoRx, Inc., announced today the appointment of Dr. Ronald M. Lindsay, Ph.D., former chief scientific officer and vice president of research and development at diaDexus, Inc., to its board of directors. Dr. Lindsay has more than 20 years experience in neuroscience, cancer, and genomics in the biopharmaceutical industry, including key leadership roles at companies such as Millenium Pharmaceuticals Inc., (NASDAQ: MLNM) and Regeneron Pharmaceuticals Inc., (NASDAQ: REGN). He joins HistoRx at a strategic time, as the Company continues to advance its proprietary quantitative protein diagnostic technology, AQUA(TM).
